Gene: FAM172A
Official Full Name: ARB2 cotranscriptional regulator Aprovided by HGNC
Gene Summary: Predicted to contribute to siRNA binding activity. Predicted to be involved in neural crest cell development; regulation of alternative mRNA splicing, via spliceosome; and regulatory ncRNA-mediated heterochromatin formation. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25267 | FAM172A Knockout cell line (HeLa) | Human | FAM172A | 1:3~1:6 | Negative | Online Inquiry |
KO25268 | FAM172A Knockout cell line (HCT 116) | Human | FAM172A | 1:2~1:4 | Negative | Online Inquiry |
KO25269 | FAM172A Knockout cell line (HEK293) | Human | FAM172A | 1:3~1:6 | Negative | Online Inquiry |
KO25270 | FAM172A Knockout cell line (A549) | Human | FAM172A | 1:3~1:4 | Negative | Online Inquiry |
FAM172A Gene Knockout Cell Lines are genetically modified cellular models specifically designed to facilitate in-depth studies of the FAM172A gene's function and its associated pathways. These cell lines have been engineered using CRISPR-Cas9 technology to create targeted gene disruptions, enabling researchers to explore how loss of FAM172A influences cellular behavior, signaling mechanisms, and disease states.
The primary function of FAM172A Gene Knockout Cell Lines lies in their capacity to mimic the genetic alterations found in various diseases, serving as vital tools for elucidating the role of FAM172A in specific biological processes. By observing the phenotypic and molecular changes that occur in these knockout lines, researchers can dissect the gene's involvement in cellular proliferation, differentiation, and apoptosis. Furthermore, these models are invaluable for drug discovery and therapeutic development, as they provide a controlled environment to assess the efficacy of compounds targeting pathways influenced by the FAM172A gene.
In both research and clinical applications, the FAM172A Gene Knockout Cell Lines are critical for advancing our understanding of genetic regulation and its implications in diseases such as cancer and neurodegeneration. Unlike traditional cell line models, these knockout lines offer specificity and precision, allowing researchers to draw clearer parallels between in vitro findings and in vivo phenomena.
The advantages of using FAM172A Gene Knockout Cell Lines include their generation of standardized genetic backgrounds, high reproducibility, and the potential for rapid adaptation in various experimental setups. Compared to alternative methods like RNA interference, which may only temporarily reduce gene expression, these knockout cell lines provide a permanent and robust solution for studying gene function.
For researchers and clinicians aiming to push the boundaries of genetic research and therapeutic development, investing in FAM172A Gene Knockout Cell Lines is invaluable. They deliver high-impact insights into gene-specific roles and their interactions within complex cellular systems. With our company’s extensive expertise in gene editing and commitment to providing cutting-edge biological products, we ensure that you receive superior models optimized for your research needs, supporting breakthroughs in understanding and treating multifaceted diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.